BionIT Labs Srl appears in FDA records as the applicant for cutaneous electrode devices under product code GXY, regulation 21 CFR 882.1320, Class II, with the Neurology classification panel. The company’s own datasheets describe non-invasive surface EMG electrodes designed for controlling myoelectric prostheses and orthosis, without a measuring function. Its published materials also describe the Adam’s Hand and accessories, positioning the electrode line as a component of a broader upper-limb prosthetics product line. [1][2][7][9]

Electrode products and stated intended use

The Remote Wave Electrode AE03-NN datasheet identifies the device as a non-invasive surface EMG electrode designed for controlling myoelectric prostheses and orthosis, without measuring function. The reference code AE03-NN-01 varies by notch frequency code, with 50 Hz and 60 Hz options listed. The earlier Wave Electrode AE02-NN datasheet uses the same intended-use wording and the same 50 Hz and 60 Hz notch filter options. [2][7]

A quick start guide published by the manufacturer describes Wave Electrode as an analog EMG electrode developed to detect the patient’s surface electromyographic signal and to integrate into the prosthetic socket to control a myoelectric device. The guide states that its content is intended for the operator or clinician and does not replace the user manual, which accompanies the product. [5]

FDA submissions and clearance dates

FDA records show K260453 for Remote Wave Electrode (AE03-50) and Remote Wave Electrode (AE03-60), received February 11, 2026, with a substantial equivalence determination letter dated March 12, 2026. The letter lists regulation number 21 CFR 882.1320, regulatory Class II, product codes GXY and IQZ, and names K242326, the Primary Wave Electrode by BionIT Labs Srl, as the legally marketed predicate device. [9]

A separate FDA record, K262755, covers Wave Electrode and Remote Wave Electrode under product code GXY, with a decision date of November 6, 2026 and a decision description of Substantially Equivalent. The applicant address in that record is Via Cracovia 1, Soleto, Italy, which is a filing address rather than a verified headquarters. [1]

Portfolio snapshot and its limits

The linked filing collection contains one 510(k) record, and its decision count shows one substantially equivalent decision. The smaller record sample likewise contains one substantially equivalent decision. These figures describe the linked filings as retrieved and do not represent total company sales, total portfolio size or safety performance. [1]

Broader product line as published by the company

The manufacturer’s sales booklet presents Adam’s Hand and Adam’s Hand Plus technical details, products and accessories, commercial codes, and customer support and reimbursement content. It also lists BionIT Labs Inc. in Brooklyn, New York, as a contact entity, distinct from the Italian applicant named in FDA filings. [4]

The company’s accessories page lists ThunderCell Battery and Wave Electrode, describing the battery as an interchangeable lithium-ion unit with 950 mAh capacity and USB-C charging. The page carries a notice that its contents are intended for the operator or clinician and do not replace the product manual. [3]